Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting ß<sub>2</sub>-agonist) in asthma patients: a narrative review.

Wechsler, Michael E; Oppenheimer, John J

Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting ß₂-agonist) in asthma patients: a narrative review.

Wechsler, Michael E; Oppenheimer, John J.

Affiliation

Wechsler ME; Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA.
Oppenheimer JJ; Pulmonary and Allergy Associates, Morristown; UMDNJ-Rutgers, Newark, NJ, USA.

J Asthma ; 60(9): 1633-1645, 2023 09.

Article in En | MEDLINE | ID: mdl-36964764

Subject(s)

Asthma; Pulmonary Disease, Chronic Obstructive; Humans; Asthma/drug therapy; Asthma/chemically induced; Muscarinic Antagonists/therapeutic use; Muscarinic Antagonists/adverse effects; Pulmonary Disease, Chronic Obstructive/diagnosis; Quality of Life; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Nebulizers and Vaporizers; Drug Therapy, Combination; Adrenal Cortex Hormones

Key words

Asthma; management; open-inhaler triple therapy; single-inhaler triple therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Asthma / Pulmonary Disease, Chronic Obstructive Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: J Asthma Year: 2023 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google